The study aims to synthesize and compile Philippine medicinal plants with inhibitory properties against SARS-COV-2 and other viruses, and to provide the framework for proactive investments in researches based on Philippine medicinal plant-derived vaccines or drugs to treat COVID-19 within the course of six (6) months.